Matt discusses the potential of Torn Two, a catalytic inhibitor of mtor, to equally inhibit both mtor complex one and mtor complex two. He highlights the need for further research on its effects on aging in mice and the importance of testing Torque One versus Torque Two. Additionally, he shares insights on the relevance of Torn Two in studying mitochondrial dysfunction and mitochondrial disease.
